Inventor · disambiguated record
Venkatraman Mohan
Also filed as: MOHAN VENKATRAMAN
18 granted patents·3 pending applications·965 citations·filing 1994–2015
96Inventor score
Files withISIS PHARMACEUTICALS INC15HONEYWELL INT INC2JOHNSON & JOHNSON PHARM RES1MANOHARAN MUTHIAH1
Top patents by PatentIndex Score
21 records- 0198US6534639B1Guanidinium functionalized oligonucleotides and method/synthesisISIS PHARMACEUTICALS INC·Filed 2000·Granted Mar 18, 2003·261 cites·26 claims
- 0298US5554746ALactam nucleic acidsISIS PHARMACEUTICALS INC·Filed 1994·Granted Sep 10, 1996·160 cites·6 claims
- 0391US6737520B2Oligonucleotides having A-DNA form and B-DNA form conformational geometryISIS PHARMACEUTICALS INC·Filed 2002·Granted May 18, 2004·35 cites·38 claims
- 0490US6967242B2Antimicrobial 2-deoxystreptamine compoundsISIS PHARMACEUTICALS INC·Filed 2002·Granted Nov 22, 2005·35 cites·16 claims
- 0590US6271358B1RNA targeted 2′-modified oligonucleotides that are conformationally preorganizedISIS PHARMACEUTICALS INC·Filed 1998·Granted Aug 7, 2001·192 cites·28 claims
- 0689US7119184B2Oligonucleotides having A-DNA form and B-DNA form conformational geometryISIS PHARMACEUTICALS INC·Filed 2001·Granted Oct 10, 2006·28 cites·26 claims
- 0789US6759523B2Antimicrobial 2-deoxystreptamine compoundsISIS PHARMACEUTICALS INC·Filed 2000·Granted Jul 6, 2004·30 cites·19 claims
- 0885US6369209B1Oligonucleotides having A-DNA form and B-DNA form conformational geometryISIS PHARMACEUTICALS INC·Filed 1999·Granted Apr 9, 2002·66 cites·29 claims
- 0984US6770486B1Optimization of ligand affinity for RNA targets using mass spectrometryISIS PHARMACEUTICALS INC·Filed 2000·Granted Aug 3, 2004·22 cites·16 claims
- 1083US10336690B2Methods and systems for processing an acetonitrile waste streamHONEYWELL INT INC·Filed 2015·Granted Jul 2, 2019·2 cites·12 claims
- 1183US6084082ALactam nucleic acidsISIS PHARMACEUTICALS INC·Filed 1998·Granted Jul 4, 2000·24 cites·14 claims
- 1277US6541456B1Antimicrobial 2-deoxystreptamine compoundsISIS PHARMACEUTICALS INC·Filed 1999·Granted Apr 1, 2003·33 cites·14 claims
- 1374US6914148B2Guanidinium functionalized intermediatesISIS PHARMACEUTICALS INC·Filed 2002·Granted Jul 5, 2005·5 cites·5 claims
- 1474US6593466B1Guanidinium functionalized nucleotides and precursors thereofISIS PHARMACEUTICALS INC·Filed 1999·Granted Jul 15, 2003·28 cites·16 claims
- 1573US6969763B1Molecular interaction sites of interleukin-2 RNA and methods of modulating the sameISIS PHARMACEUTICALS INC·Filed 1999·Granted Nov 29, 2005·41 cites·4 claims
- 1658US9556124B2Methods for removing triazine from N-methylimidazole for synthesis of oligonucleotideHONEYWELL INT INC·Filed 2014·Granted Jan 31, 2017·0 cites·10 claims
- 1753US2007123702A1Oligonucleotdies having A-DNA form and B-DNA form conformational geometryMANOHARAN MUTHIAH·Filed 2005·Application pending·0 cites
- 1850US2003083483A1Molecular interaction sites of vimentin RNA and methods of modulating the sameFiled 2002·Application pending·0 cites
- 1949US5866691ALactam nucleic acidsISIS PHARMACEUTICALS INC·Filed 1996·Granted Feb 2, 1999·3 cites·11 claims
- 2046US2003017483A1Modulation of molecular interaction sites on RNA and other biomoleculesFiled 2002·Application pending·0 cites
- 2144US7550474B2Substituted phenyl acetamides and their use as protease inhibitorsJOHNSON & JOHNSON PHARM RES·Filed 2004·Granted Jun 23, 2009·0 cites·42 claims
Join the waitlist — get patent alerts
Get an alert when Venkatraman Mohan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →